RetinalGenix Technologies (RTGN) Notes Payables (2022 - 2026)

RetinalGenix Technologies (RTGN) posted Notes Payables of $49000.0 for Q1 2026, little changed sequentially from $49000.0 in Q4 2025.

RetinalGenix Technologies (RTGN) Notes Payables (2022 - 2026) Analysis & Trends

RetinalGenix Technologies has reported Notes Payables for 4 years, with the latest figure at $49000.0 in Q1 2026.

Quarterly Notes Payables changed N/A year-over-year to $49000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $49000.0 (changed N/A YoY) and the FY2025 annual result came in at $49000.0, changed N/A from the prior year.
Notes Payables steadied at $49000.0 in Q1 2026 per RTGN's latest filing, from $49000.0 in the prior quarter.
Over five years, Notes Payables peaked at $49000.0 in Q4 2022 and troughed at $49000.0 in Q4 2022.
A 4-year average of $49000.0 and a median of $49000.0 in 2022 frame the typical range for Notes Payables.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	198.95 Bn	193.34 Bn	7.27 Bn
2	Stryker	127.40 Bn	123.93 Bn	4.50 Bn
3	Medtronic	118.77 Bn	109.55 Bn	6.41 Bn
4	Boston Scientific	73.24 Bn	72.71 Bn	3.85 Bn
5	Edwards Lifesciences	51.95 Bn	47.70 Bn	1.35 Bn
6	Dexcom	34.39 Bn	32.44 Bn	830.00 Mn
7	GE HealthCare Technologies	33.87 Bn	31.76 Bn	2.18 Bn
8	Koninklijke Philips	26.34 Bn	23.02 Bn	4.55 Bn
9	Steris	23.04 Bn	22.56 Bn	684.20 Mn
10	RetinalGenix Technologies	75.02 Mn	75.02 Mn	-

Download Data